POZZI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 2.995
EU - Europa 2.078
AS - Asia 691
AF - Africa 94
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 5.878
Nazione #
US - Stati Uniti d'America 2.989
IT - Italia 613
UA - Ucraina 369
SG - Singapore 292
IE - Irlanda 238
CN - Cina 197
SE - Svezia 196
DE - Germania 193
DK - Danimarca 139
FR - Francia 132
TR - Turchia 95
FI - Finlandia 92
KR - Corea 80
CI - Costa d'Avorio 79
GB - Regno Unito 53
IN - India 23
BR - Brasile 15
BE - Belgio 13
RO - Romania 13
MA - Marocco 12
AT - Austria 7
CA - Canada 6
PL - Polonia 5
EU - Europa 4
HR - Croazia 4
ES - Italia 2
JP - Giappone 2
NL - Olanda 2
SM - San Marino 2
AO - Angola 1
AU - Australia 1
BJ - Benin 1
ET - Etiopia 1
HU - Ungheria 1
ID - Indonesia 1
MD - Moldavia 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 5.878
Città #
Chandler 422
Jacksonville 382
Dublin 233
Boardman 232
Fairfield 202
Ashburn 200
Singapore 154
Wilmington 148
New York 122
Marche 113
Des Moines 93
Lawrence 84
Princeton 83
San Mateo 80
Abidjan 79
Houston 77
Seattle 76
Ann Arbor 69
Woodbridge 61
Cambridge 59
Turin 51
Centro 37
San Diego 36
Ancona 33
Beijing 30
Tolentino 27
Shanghai 23
Helsinki 22
Wuhan 20
Washington 19
Milan 17
Berlin 15
Los Angeles 14
Brussels 13
Guangzhou 13
Redmond 13
Brasov 12
London 12
Civitanova Marche 10
Wuxi 10
Dallas 9
Delhi 9
Pune 9
Boydton 7
Cagliari 7
Jiaxing 7
Norwalk 7
Pesaro 7
Porto 7
Vienna 7
Frederico Westphalen 6
Jinhua 6
Livorno 6
Rome 6
Aversa 5
Iesi 5
Quanzhou 5
Torino 5
Ascoli Piceno 4
Falconara Marittima 4
Genoa 4
Heze 4
Munich 4
Perugia 4
Radomsko 4
Seoul 4
Torre Del Greco 4
Yiwu 4
Zagreb 4
Clifton 3
Foggia 3
Izmir 3
Loro Piceno 3
Montecassiano 3
Namhyang-dong 3
Ottawa 3
Pavia 3
Zibo 3
Amsterdam 2
Bhubaneswar 2
Borgo Maggiore 2
Brescia 2
Castiglione delle Stiviere 2
Cattolica 2
Chennai 2
Chiaravalle 2
Chiswick 2
Fort Collins 2
Frankfurt am Main 2
Imola 2
Lanuvio 2
Lauria 2
Monte San Vito 2
Montelupone 2
Naples 2
Nuremberg 2
Osimo 2
Pisa 2
Rieti 2
Rovereto 2
Totale 3.631
Nome #
Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP syndrome. 120
Involvement of the oral cavity in psoriasis: results of a clinical study 118
Clinical performance and utility of a NNMT-based urine test for bladder cancer 107
Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures 106
Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells 102
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 101
Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts 101
Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma 96
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 96
Apoptosis pathway is involved in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 93
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 92
Espressione della trombomodulina placentare negli aborti spontanei ricorrenti. 91
Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines 91
RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells. 91
Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. 88
Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 88
Inflammatory cytokines patterns in the placenta of pregnancies complicated by Hellp syndrome. 85
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 83
Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. 82
Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse 81
Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. 80
Inflammatory cytokines pattern in recurrent miscarriage. 79
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 79
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 78
Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 77
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 77
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 76
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma. 75
Fattore di differenziamento eritrocitario (EDRF) nella patologia ostetrica. 74
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 74
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. 72
Aspetti infiammatori, trombotici e immunitari nella biologia dell’aborto spontaneo ricorrente. 69
RNA-mediated gene silencing NNMT decreases tumorigenity in OSCC cells. 69
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 67
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 67
Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase. 66
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 66
Enhanced expression of amyloid precursor protein in platelets from patients with Alzheimer’s disease and frontotemporal lobar degeneration. 66
Inflammatory cytokines pattern in recurrent miscarriage. 65
The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. 65
Association of miR-126 with soluble mesothelin-related peptides: a novel marker for malignant mesothelioma. 64
Espressione di Pokemon nel carcinoma orale. 64
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 64
CSCs selection, characterization and tumorigenic potential in OSCC. 64
Enhanced expression of nicotinamide N-methyltransferase in non-small cell lung cancer: potential for the development of a targeted anticancer therapy. 63
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 63
Identification and characterization of cancer stem cells from Head and Neck squamous cell carcinoma cell line Hep-2. 61
Natural extracts from the genus Beta and their cytotoxic activity on T24 human bladder cancer cells 61
L'enzima nicotinamide N-Metiltrasferasi: un nuovo marker diagnostico e target terapeutico nel carcinoma orale 60
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 59
Pattern di espressione placentare delle citochine infiammatorie nella HELLP syndrome. 56
Nicotinamide N-methyltransferase: a promising marker for oral cancer. 56
Paraoxonase 2 (PON2) expression in bladder cancer 55
Enhanced expression of paraoxonase 2 in human bladder cancer 55
Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma 54
Salivary and tissue Nicotinamide N-methyltrasferase: potential use for early and non-invasive diagnosis of oral squamous cell carcinoma. 54
Neurotrophins and receptors pattern expression in placentas from pregnancies complicated by HELLP Syndrome and Intrauterine Growth Restriction (IUGR). 54
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 54
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 53
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 52
RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. 52
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 52
Micro-RNA profiling identifies mir-126 as promising biomarker for prognosis and early detection of malignant mesothelioma. 50
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 50
Nicotinamide N-Methyltransferase: a promising biomarker for early diagnosis and prognostic monitoring of oral squamous cell carcinoma. 49
Nicotinamide n-methyltransferase: a new diagnostic marker and therapeutic target for oral carcinoma. 49
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 49
L’enzima nicotinamide N-metiltrasferasi potenziale marcatore diagnostico e prognostico nel carcinoma renale. 48
Nicotinamide N-methyltransferase as effective diagnostic tool and promising therapeutic target for oral cancer. 47
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 46
Nicotinamide N-methyltransferase: a potential target molecule for effective therapy and early diagnosis of oral squamous cell carcinoma. 46
Inflammatory cytokines and receptors in placentas from pregnancies complicated by HELLP syndrome. 46
Profilo dell’espressione dei geni coinvolti nel pathway dell’apoptosi nel carcinoma orale. 46
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 46
Tissue and salivary Nicotinamide N-Methyltransferase: promising results for early and non-invasive diagnosis of oral squamous cell carcinoma. 44
Quantitative analysis of NNMT mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection. 43
Gene silencing of Nicotinamide N-methyltransferase in oral cancer cell lines: effects on tumor cell proliferation. 43
NNMT (nicotinamide N-methyltransferase). 43
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 40
Nicotinamide N-Methyltransferase as potential predictor of lymph node metastasis in Oral Squamous Cell Carcinoma. 40
Epithelial Biological Response to Machined Titanium vs. PVD Zirconium-Coated Titanium: An In Vitro Study 38
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 37
Nicotinamide N-methyltransferase: a new prognostic marker for oral squamous cell carcinoma. 37
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 36
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 36
Nicotinamide N-methyltransferase: a potential prognostic marker for oral squamous cell carcinoma. 36
Real-Time PCR analysis of NNMT expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection. 35
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 35
Gene silencing of Nicotinamide N-methyltransferase in oral cancer cell lines: effects on tumor cell proliferation. 32
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 31
Paraoxonase-2 expression in oral squamous cell carcinoma 31
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 29
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 27
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 27
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 27
Paraoxonase-2 (PON2) is upregulated in triple negative breast cancer and contributes to the tumor progression and chemoresistance 26
The Effect and the Potential Use of Magnetic–Dam Barrier in Guided Bone Regeneration: A Laboratory Study 24
Role of nicotinamide N-methyltransferase in human osteosarcoma: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 20
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 19
Involvment of the enzyme nicotinamide N-methyltransferase in proliferation, invasive capacity and chemosensitivity of human osteosarcoma. 19
Totale 6.050
Categoria #
all - tutte 37.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020449 0 0 0 0 88 6 84 14 85 6 67 99
2020/2021859 36 98 117 3 103 40 104 35 96 84 110 33
2021/2022628 29 167 14 23 0 19 23 59 33 60 49 152
2022/20231.409 100 170 101 119 83 194 18 88 336 13 121 66
2023/20241.136 169 26 82 126 145 183 14 34 20 90 52 195
2024/2025591 287 144 101 46 13 0 0 0 0 0 0 0
Totale 6.183